Bashing accelerated approval isn’t supported by the data
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The use of accelerated approval for drugs is being questioned, with some arguing that the data does not support criticism of this approach. An alternative method, known as progressive approval, is being proposed as a potentially better way to get drugs to market. The effectiveness of different approval processes is a topic of discussion.